Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TARGET-ASPECT (Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke)

NCT07069452 is registered in ClinicalTrials.gov with Centre Hospitalier de Gonesse as lead sponsor.

NCT NCT07069452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07069452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TARGET-ASPECT (Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke)
Lead sponsor
Centre Hospitalier de Gonesse
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2025
Completion date
January 15, 2026
Enrollment
152 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain ischemia, magnetic resonance imaging, outcome assessment (health care), prognosis, stroke, ischemic, thrombectomy, thrombolytic therapy